MS

Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales
Fierce Pharma
Wed, 07/20/22 - 11:17 pm
Biogen
whistleblowers
multiple sclerosis
MS
kickbacks
After ulcerative colitis flop, Immunic regains some momentum with multiple sclerosis update
Fierce Biotech
Wed, 06/15/22 - 10:58 am
Immunic
MS
multiple sclerosis
ulcerative colitis
vidofludimus calcium
Research Shows Stem Cells Might Become a Game Changer for Multiple Sclerosis
BioSpace
Thu, 06/9/22 - 10:48 am
R&D
stem cells
multiple sclerosis
MS
Biogen taps digital therapeutics biotech for music-based therapy to help people with MS improve their walking
Endpoints
Sun, 05/8/22 - 12:10 pm
Biogen
digital healthcare
digital therapeutics
MedRhythms
MS
multiple sclerosis
Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute
Reuters
Thu, 03/17/22 - 10:25 am
Biogen
Mylan
Tecfidera
patents
multiple sclerosis
MS
Novartis blocks generic to MS blockbuster Gilenya in US patent dispute
Pharmaforum
Tue, 01/4/22 - 10:50 am
Novartis
Gilenya
patents
HEC Pharma
generics
multiple sclerosis
MS
Biogen takes another blow as appeal for Tecfidera patent revival falls short
Fierce Pharma
Tue, 11/30/21 - 11:38 pm
Biogen
Tecfidera
patents
multiple sclerosis
MS
A remyelinating agent remains a distant hope
EP Vantage
Thu, 10/14/21 - 10:56 am
Atara
ATA188
remyelination
multiple sclerosis
MS
Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
PM Live
Wed, 10/13/21 - 10:47 am
Biogen
MS
multiple sclerosis
COVID-19
vaccines
Roche and Temedica Pilot Digital Companion for MS Patients
BioSpace
Wed, 09/15/21 - 10:18 pm
Roche
Temedica
MS
multiple sclerosis
devices
mobile apps
Study: Drug Candidate Improves Brain Energy Metabolism in Parkinson’s, MS
BioSpace
Thu, 08/5/21 - 11:19 pm
Clene
Parkinson's Disease
MS
clinical trials
Biogen builds MS pipeline via $125m deal with China’s InnoCare
Pharmaforum
Tue, 07/13/21 - 10:39 am
Biogen
MS
multiple sclerosis
China
InnoCare
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats
Fierce Pharma
Thu, 07/1/21 - 11:08 pm
Teva Pharmaceutical
Mylan
Viatris
MS
generics
Copaxone
After FDA rejection, EU says yes to Sanofi’s Aubagio in kids with MS
Pharmaforum
Mon, 06/21/21 - 11:03 am
Sanofi
Aubatio
MS
multiple sclerosis
FDA
Europe
Novartis plots 'next frontier' of MS treatment — and it could spell a buyout for a small Swiss player
Endpoints
Tue, 06/1/21 - 11:10 am
Novartis
MS
multiple sclerosis
CLS12311
Cellerys
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Endpoints
Fri, 04/16/21 - 09:57 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Here's a Multibillion-Dollar Market for Johnson & Johnson
Motley Fool
Tue, 04/13/21 - 10:26 am
JNJ
Ponvory
MS
multiple sclerosis
Helius Medical’s device gets FDA all clear to stimulate the brain via the tongue
MedCity News
Mon, 04/5/21 - 10:13 pm
Helius
devices
FDA
brain stimulation
multiple sclerosis
MS
BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
BioSpace
Wed, 03/24/21 - 11:15 pm
BrainStorm Cell Therapeutics
MS
clinical trials
multiple sclerosis
FDA approves Janssen’s PONVORY for treatment of multiple sclerosis
Pharmaceutical Business Review
Mon, 03/22/21 - 10:35 am
JNJ
Janssen
FDA
Ponvory
relapsing multiple sclerosis
MS

Pages